![]() |
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
INFLAMMATION AND IMMUNOPHARMACOLOGY
B-Dependent Signaling by Directly Targeting p65
Departments of Critical Care Medicine (Y.H., J.A.E., R.Y., R.L.D., M.P.F.), Pathology (R.L.D.), and Surgery (M.P.F.), University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania
Ethyl pyruvate has been shown to have anti-inflammatory properties in numerous cell culture and animal studies. In this series of experiments, we tested the hypothesis that ethyl pyruvate inhibits signaling by the pro-inflammatory transcription factor, NF-
B. Ethyl pyruvate inhibited luciferase expression in lipopolysaccharide-stimulated murine macrophage-like RAW 264.7 cells transfected with an NF-
B-dependent luciferase reporter vector. Ethyl pyruvate also decreased NF-
B DNA-binding activity in lipopolysaccharide-stimulated RAW 264.7 cells and decreased lipopolysaccharide-induced expression of an NF-
B-dependent gene, inducible nitric oxide synthase. Ethyl pyruvate had no effect on the degradation of I
B
or I
B
in lipopolysaccharide-stimulated RAW 264.7 cells, suggesting that ethyl pyruvate acts distally to this step in the activation of NF-
B. In a cell-free system, binding of p50 homodimers to an NF-
B consensus oligonucleotide sequence was unaffected by ethyl pyruvate over a wide range of concentrations, indicating that ethyl pyruvate probably does not modify or interact with the p50 subunit of NF-
B. In contrast, ethyl pyruvate inhibited DNA binding by ectopically overexpressed wild-type p65 homodimers. However, ethyl pyruvate failed to inhibit the DNA-binding activity of homodimers of an overexpressed mutant form of a p65 with substitution of serine for cysteine 38. Taken together, these results suggest that ethyl pyruvate inhibits DNA-binding by covalently modifying p65 at Cys38. We conclude that some of the beneficial anti-inflammatory effects of ethyl pyruvate may be due to modification of p65, thereby inhibiting signaling via the NF-
B pathway.
Address correspondence to: Dr. Mitchell P. Fink, Department of Critical Care Medicine, 615 Scaife Hall, 3550 Terrace Street, Pittsburgh, PA 15261. E-mail: finkmp{at}ccm.upmc.edu
This article has been cited by other articles:
![]() |
A. Leelahavanichkul, H. Yasuda, K. Doi, X. Hu, H. Zhou, P. S. T. Yuen, and R. A. Star Methyl-2-acetamidoacrylate, an ethyl pyruvate analog, decreases sepsis-induced acute kidney injury in mice Am J Physiol Renal Physiol, December 1, 2008; 295(6): F1825 - F1835. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Su, Z. Wang, Y. Cai, M. Remmelink, and J.-L. Vincent Beneficial Effects of Ethyl Pyruvate in Septic Shock From Peritonitis Arch Surg, February 1, 2007; 142(2): 166 - 171. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Cui, F. J. Schopfer, J. Zhang, K. Chen, T. Ichikawa, P. R. S. Baker, C. Batthyany, B. K. Chacko, X. Feng, R. P. Patel, et al. Nitrated Fatty Acids: Endogenous Anti-inflammatory Signaling Mediators J. Biol. Chem., November 24, 2006; 281(47): 35686 - 35698. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-Y. Lee, W.-J. Kim, Y.-J. Kang, Y.-M. Jung, Y.-M. Kang, K. Suk, J.-E. Park, E.-M. Choi, B.-K. Choi, B. S. Kwon, et al. Z39Ig is expressed on macrophages and may mediate inflammatory reactions in arthritis and atherosclerosis J. Leukoc. Biol., October 1, 2006; 80(4): 922 - 928. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. B. Milbrandt, A. Ishizaka, and D. C. Angus Update in critical care 2005. Am. J. Respir. Crit. Care Med., April 15, 2006; 173(8): 833 - 841. [Full Text] [PDF] |
||||
![]() |
S. Aggarwal, H. Ichikawa, Y. Takada, S. K. Sandur, S. Shishodia, and B. B. Aggarwal Curcumin (Diferuloylmethane) Down-Regulates Expression of Cell Proliferation and Antiapoptotic and Metastatic Gene Products through Suppression of I{kappa}B{alpha} Kinase and Akt Activation Mol. Pharmacol., January 1, 2006; 69(1): 195 - 206. [Abstract] [Full Text] [PDF] |
||||